ABEONA THERAPEUTICS INC.
ABEODrugs in Pipeline
6
Phase 3 Programs
4
Upcoming Catalysts
1
Next Catalyst
Aug 13, 2026
16dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How ABEO's past catalysts played out
ofloxacin
Diabetic Foot Ulcers
EB-101
Epidermolysis Bullosa
EB-101 Surgical application of RDEB wounds
Epidermolysis Bullosa
MSI-78
Diabetic Foot Ulcers
EcoNail™ (econazole 5%/SEPA® 18% nail lacquer)
Onychomycosis
LZRSE-Col7A1 Engineered Autologous Epidermal Sheets
Epidermolysis Bullosa Dystrophica
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ofloxacin | Phase 3 | Diabetic Foot Ulcers | - | |
EB-101 | Phase 3 | Epidermolysis Bullosa | - | - |
EB-101 Surgical application of RDEB wounds | Phase 3 | Epidermolysis Bullosa | - | - |
MSI-78 | Phase 3 | Diabetic Foot Ulcers | - | - |
EcoNail™ (econazole 5%/SEPA® 18% nail lacquer) | Phase 2 | Onychomycosis | - | - |
LZRSE-Col7A1 Engineered Autologous Epidermal Sheets | Phase 2 | Epidermolysis Bullosa Dystrophica | - | - |
Diabetic Foot Ulcers
2 drugs in this indication
Epidermolysis Bullosa
2 drugs in this indication
Onychomycosis
1 drug in this indication
Epidermolysis Bullosa Dystrophica
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in ABEONA THERAPEUTICS INC.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in ABEONA THERAPEUTICS INC.'s (ABEO) pipeline across Phase 3, Phase 2. Its lead program is ofloxacin (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ABEONA THERAPEUTICS INC.'s next FDA catalyst?→
ABEONA THERAPEUTICS INC.'s (ABEO) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ABEO biotech catalysts?→
Add ABEO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ABEONA THERAPEUTICS INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.